新興傳染病及感管流行病學
Epidemiology of emerging infectious diseases (EID) and healthcare-associated infections (HAI)
| 節 | 週三 |
|---|---|
7 15:30–16:20 | 新興傳染病及感管流行病學 YL405（陽明） 2 節連堂 |
8 16:30–17:20 |
* 根據陽明交大上課時間表所列
1. Epidemiological methodology of and application to emerging infectious diseases. 2. Basic knowledge of virology, immunology, vaccinology,and pathogenesis of emerging infectious diseases. 3. Introduction and control of health-associated infections.
教師未提供此項資料
無備註
1. Understand the epidemiological methodology of and application to emerging infectious diseases. 2. Understand the principle of management of emerging infectious diseases and health-associated infections.
教師未提供此項資料
教師未提供此項資料
| 週次 | 主題 |
|---|---|
| 第 1 週 | 1. COVID-19 fatality global evidence: From testing number, vaccination rate to non-pharmaceutic interventions 111-09-14 |
| 第 2 週 | 2. Introduction of EID and healthcare-associated infection (HAI) 111-09-21 |
| 第 3 週 | 3. Outbreak investigation and biostatistics 111-09-28 |
| 第 4 週 | 4. Virology of COVID-19 111-10-05 |
| 第 5 週 | 5. Genetic characterization and evolution of COVID-19 111-10-12 |
| 第 6 週 | 6. Immunopathogenesis of COVID-19 111-10-19 |
| 第 7 週 | 7. The role of pathology in outbreak investigation 111-10-26 |
| 第 8 週 | 期中考週不上課 111-11-02 |
| 第 9 週 | 8. Laboratory diagnosis of EID 111-11-09 |
| 第 10 週 | 9. Enhanced traffic control bundle for COVID-19 111-11-16 |
| 第 11 週 | 10. Clinical characterization and management of emerging viral infections 111-11-23 |
| 第 12 週 | 11. Introduction and control of Healthcare-associated infections 111-11-30 |
| 第 13 週 | 12. Vaccination development for COVID-19 111-12-07 |
| 第 14 週 | 13. Multi-drug resistant organism (MDRO) 111-12-14 |
| 第 15 週 | 14. Elimination of viral hepatitis 111-12-21 |
| 第 16 週 | 15. Final Exam 111-12-28 |
| 第 17 週 | 彈性補充教學 |
| 第 18 週 | 彈性補充教學 |
教師未提供此項資料
- 地點
- 教師未提供此項資料
- 時間
- 教師未提供此項資料
- 聯絡方式
- 教師未提供此項資料